Based on the increasing clinical interest in innovative antineoplastic “epi-drugs” that might silence DNMT function, the crocin inhibitory potential of DNMTs might be mainly exploited in terms of cancer therapy [58,59]. The gene discussed is DNMT1; the disease is cancer.